Evidence map›Paper›PMID 30987995›Full record

ArticleBMJ open2019

Designing and evaluating provider results-based financing for tuberculosis care in Georgia: a realist evaluation protocol.

Bruno Marchal, Ariadna Nebot Giralt, Lela Sulaberidze, Ivdity Chikovani, Ibukun-Oluwa Omolade Abejirinde

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bruno MarchalDepartment of Public Health, Institute of Tropical Medicine, Health Systems and Equity Unit, Antwerp, Belgium.
Ariadna Nebot GiraltDepartment of Public Health, Institute of Tropical Medicine, Health Systems and Equity Unit, Antwerp, Belgium.
Lela SulaberidzeCuratio International Foundation, Tbilisi, Georgia.
Ivdity ChikovaniCuratio International Foundation, Tbilisi, Georgia.
Ibukun-Oluwa Omolade AbejirindeDepartment of Public Health, Institute of Tropical Medicine, Health Systems and Equity Unit, Antwerp, Belgium.ORCID 0000-0003-0139-0541

Funding

Medical Research Council MR/P015018/1Wellcome Trust
6 · The paper itself

Abstract

introductionIn 2016, Georgian researchers and policymakers were developing a policy to improve the performance of the national tuberculosis (TB) control programme. The research programme 'Designing and Evaluating Provider Results-Based Financing for Tuberculosis Care in Georgia: Understanding Costs, Mechanisms of Effect and Impact (Results4TB)' was initiated to inform the policy formulation phase, document the policy implementation and assess the effectiveness, cost-effectiveness and the processes of change. To achieve this, the research team intends to combine an impact evaluation, a cost-effectiveness study and a realist evaluation (RE) within an overarching theory-informed design. This protocol is the RE component of the programme.

methodsA realist methodological approach will be adopted to guide the research design and evaluation. RE answers the question of 'what works in which conditions for whom?' and starts with the development of an initial programme theory (IPT). The IPT will feed into other phases of the realist research cycle (study design, data collection, data analysis and synthesis and theory refinement). Data will be collected in a multiple embedded case study design (five intervention and three control sites) through document reviews, in-depth interviews, non-participant observations and context mapping at facility and national levels. Additional data from other research components (cost-effectiveness and impact evaluation) will aid data triangulation. ETHICS AND DISSEMINATION: The Institutional Review Boards of the National Centre for Disease Control and Public Health in Georgia (ref. IRB # 2018-019) and the Institute of Tropical Medicine, Antwerp (ref. IRB #- 1240/18) have granted ethical approval to the study. TRIAL REGISTRATION NUMBER: ISRCTN14667607.

Indexed as

Program EvaluationTuberculosisCost-Benefit AnalysisGeorgia (Republic)HumansPublic Healthgeorgiahealth policyrealist evaluationresearch protocolresults-based financing

Identifiers

PMID30987995
PMCPMC6500265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.